104 related articles for article (PubMed ID: 12142735)
1. Characterization of scattered neuroendocrine cells in ductal carcinoma of the pancreas.
Tezel E; Nagasaka T; Tezel G; Nakao A
Pancreas; 2002 Aug; 25(2):136-41. PubMed ID: 12142735
[TBL] [Abstract][Full Text] [Related]
2. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of endocrine differentiation in early and advanced stomach carcinoma].
Melissari M; Giordano G; Saragoni L; Bordi C
Pathologica; 1997 Apr; 89(2):133-7. PubMed ID: 9411359
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical survey for neuroendocrine cells in regional pancreatic lymph nodes: a plausible explanation for primary nodal gastrinomas? Mayo Clinic Pancreatic Surgery Group.
Perrier ND; Batts KP; Thompson GB; Grant CS; Plummer TB
Surgery; 1995 Dec; 118(6):957-65; discussion 965-6. PubMed ID: 7491540
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas.
Pilichowska M; Kimura N; Schindler M; Kobari M
Endocr Pathol; 2001; 12(2):147-55. PubMed ID: 11579680
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine differentiation in ovarian mucinous tumors.
Jiang C; Tan Y; Li E; Zhang D
Chin Med J (Engl); 2000 Jan; 113(1):70-4. PubMed ID: 11775215
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin-A expression in gastric and colon cancer tissues.
Park JG; Choe GY; Helman LJ; Gazdar AF; Yang HK; Kim JP; Park SH; Kim YI
Int J Cancer; 1992 May; 51(2):189-94. PubMed ID: 1349007
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas.
Yuan A; Liu J; Liu Y; Cui G
Pathol Oncol Res; 2007; 13(4):321-5. PubMed ID: 18158567
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation in pancreatic duct carcinoma special emphasis on duct-endocrine cell carcinoma of the pancreas.
Kamisawa T; Fukayama M; Tabata I; Isawa T; Tsuruta K; Okamoto A; Koike
Pathol Res Pract; 1996 Sep; 192(9):901-8. PubMed ID: 8950756
[TBL] [Abstract][Full Text] [Related]
14. Correlation between chromogranin-A expression and pathological variables in human colon carcinoma.
Indinnimeo M; Cicchini C; Memeo L; Stazi A; Provenza C; Ricci F; Mingazzini PL
Anticancer Res; 2002; 22(1A):395-8. PubMed ID: 12017321
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I
Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178
[TBL] [Abstract][Full Text] [Related]
16. Distribution and coexistence of chromogranin A-, serotonin- and pancreastatin-like immunoreactivity in endocrine-like cells of the human anal canal.
Hörsch D; Weihe E; Müller S; Hancke E
Cell Tissue Res; 1992 Apr; 268(1):109-16. PubMed ID: 1499046
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine-like differentiation in patients with pancreatic carcinoma.
Tezel E; Nagasaka T; Nomoto S; Sugimoto H; Nakao A
Cancer; 2000 Dec; 89(11):2230-6. PubMed ID: 11147593
[TBL] [Abstract][Full Text] [Related]
18. Dual presence of chromogranin A-like immunoreactivity in a population of endocrine-like cells and in nerve fibers in the human anal canal.
Weihe E; Hörsch D; Eiden LE; Hartschuh W
Neurosci Lett; 1991 Sep; 130(2):190-4. PubMed ID: 1795880
[TBL] [Abstract][Full Text] [Related]
19. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases.
Sellner F; Sobhian B; De Santis M; Pont J; Staettner S; Sellner S; Karner J; Klimpfinger M
Eur J Surg Oncol; 2008 Feb; 34(2):191-5. PubMed ID: 17475440
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
